Fixed-Free HTN Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03578042

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Hotel Dieu de France Hospital (from the registry)
Registry
  • NCT NCT03578042
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Lebanon (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03578042. Randomized; no masking; primary purpose treatment. Start 2017-04-01 (actual); primary completion 2019-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fixed-Free HTN Trial
Condition
Hypertension
Intervention (Drug)
Losartan and amlodipine and hydrochlorothiazide
Intervention (Drug)
Standard of care
Lead sponsor
Hotel Dieu de France Hospital (class: other)

Record details

Record id
cardio:ct-nct03578042
Content hash
42d6264ade303303eeab4103c4925ef0e29531bfd30d67286ccf03a0b42da2c4